Showing 2321-2330 of 2527 results for "".
- The American Academy of Optometry Foundation Selects the 2019 Bert C. and Lydia M. Corwin Contact Lens Residency Award Recipienthttps://modernod.com/news/the-american-academy-of-optometry-foundation-selects-the-2019-bert-c-and-lydia-m-corwin-contact-lens-residency-award-recipient/2476831/The American Academy of Optometry has named Jocelyn Ou, OD, this year’s recipient of the Bert C. and Lydia M. Corwin Contact Lens Residency award. Dr. Ou is a cornea and contact lens resident at the Ketchum Health University Eye Center in Anaheim, California, and was ch
- Staar Surgical Announces FDA IDE Clinical Study Approvalhttps://modernod.com/news/staar-surgical-announces-fda-ide-clinical-study-approval/2476825/Staar Surgical announced that the FDA, in a letter dated August 23, 2019, stated that it has determined that Staar has provided sufficient data to support initiation of a human clinical study in the United States of the EVO/EVO+ Visian Implantable Collamer Lens for myopia, and EVO/EVO+ Visian Tor
- Alcon Introduces AcrySof IQ PanOptix Trifocal IOL in the US, the First and Only FDA-Approved Trifocal Lenshttps://modernod.com/news/alcon-introduces-acrysof-iq-panoptix-trifocal-iol-in-the-us-the-first-and-only-fda-approved-trifocal-lens/2476827/Alcon announced the FDA approval and the initial commercial launch of the AcrySof IQ PanOptix Trifocal IOL, the first and only trifocal lens approved in the United States. PanOptix is clinically shown to deliver an exceptional combination of near, intermediate, and distance vision while reducing
- New Accessible Products Hotline to Offer Advice on Products for Blind or Visually Impairedhttps://modernod.com/news/new-accessible-products-hotline-to-offer-advice-on-products-for-blind-or-visually-impaired/2476823/Envision has launched a first-of-its-kind Accessible Products Hotline that aims to help consumers with vision loss find products that fit their unique accessibility needs. Funded by a grant from the Consumer Technology Association (CTA) Foundation, the hotline will be operated by the William L. H
- ProtoKinetix: Tests Show AAGP-Preserved and Enabled Retinal Cells to Mature Without Compromise after 5-Month Milestonehttps://modernod.com/news/protokinetix-tests-show-aagp-preserved-and-enabled-retinal-cells-to-mature-without-compromise-after-5-month-milestone/2476822/ProtoKinetix updated shareholders regarding ongoing third stage testing of retinal cell replacement therapy at the University of British Columbia. As previously reported, the company demonstrated the ability of AAGP to protect transplanted cells in a preclinical experimental model of retinal dege
- New World Medical Launches Ahmed ClearPath Glaucoma Drainage Devicehttps://modernod.com/news/new-world-medical-launches-ahmed-clearpath-glaucoma-drainage-device/2476814/New World Medical announced the launch of the Ahmed ClearPath glaucoma drainage device, which is available in two sizes, 350 mm2 and 250 mm.2 A unique feature of the Ahmed ClearPath implant is a flexible plate with a contour that closely conforms to the curvature of the eye
- Examining the Role of Vitamin B3 Supplementation in Reducing and Preventing Retinal Cell Damage Caused by Glaucomahttps://modernod.com/news/examining-the-role-of-vitamin-b3-supplementation-in-reducing-and-preventing-retinal-cell-damage-caused-by-glaucoma/2476813/UK-based Fight for Sight is funding researchers at Cardiff University to examine the extent to which dietary supplementation of Nicotinamide—a form of vitamin B3—can be used to reduce, and even prevent, retinal damage caused by glaucoma. This important research could help pave the way for new typ
- Alcon to Launch Precision1 Daily Disposable Contact Lenseshttps://modernod.com/news/alcon-to-launch-precision1-daily-disposable-contact-lenses/2476810/Alcon announced plans to launch Precision1 daily disposable, silicone hydrogel (SiHy) contact lenses in the United States. Precision1 features Alcon’s proprietary Smartsurface technology—a permanent, micro-thin, high-performance layer of moisture at the lens surface that helps support a stable te
- Trial of Tele-Ophthalmology System at Regional Health Board in Scotland Shows Promising Resultshttps://modernod.com/news/trial-of-tele-ophthalmology-system-at-regional-health-board-in-scotland-shows-promising-results/2476808/Researchers at the University of Strathclyde and NHS Forth Valley in Scotland have developed a tele-ophthalmology system that, according to recent data, has reduced the need for follow-up appointments and waiting times for treatments in over 50% of cases, according to a
- ProQR Announces Clearance of IND to Start Clinical Trial of QR-1123 in Patients with Autosomal Dominant Retinitis Pigmentosa (adRP)https://modernod.com/news/proqr-announces-clearance-of-ind-to-start-clinical-trial-of-qr-1123-in-patients-with-autosomal-dominant-retinitis-pigmentosa-adrp/2476802/ProQR Therapeutics announced that the FDA has cleared the investigational new drug (IND) application for QR-1123. ProQR plans to start enrolling patients in a phase 1/2 trial for QR-1123 in 2019. QR-1123 is a first-in-class investigational oligonucleotide designed to address the underlying